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Abstract
Recent information has revealed the functional diversity and importance of mitochondria in many cellular processes
including orchestrating the innate immune response. Intriguingly, several infectious agents, such as Toxoplasma, Legionella,
and Chlamydia, have been reported to grow within vacuoles surrounded by host mitochondria. Although many hypotheses
have been proposed for the existence of host mitochondrial association (HMA), the causes and biological consequences of
HMA have remained unanswered. Here we show that HMA is present in type I and III strains of Toxoplasma but missing in
type II strains, both in vitro and in vivo. Analysis of F1 progeny from a type II6III cross revealed that HMA is a Mendelian trait
that we could map. We use bioinformatics to select potential candidates and experimentally identify the polymorphic
parasite protein involved, mitochondrial association factor 1 (MAF1). We show that introducing the type I (HMA+) MAF1
allele into type II (HMA2) parasites results in conversion to HMA+ and deletion of MAF1 in type I parasites results in a loss of
HMA. We observe that the loss and gain of HMA are associated with alterations in the transcription of host cell immune
genes and the in vivo cytokine response during murine infection. Lastly, we use exogenous expression of MAF1 to show that
it binds host mitochondria and thus MAF1 is the parasite protein directly responsible for HMA. Our findings suggest that
association with host mitochondria may represent a novel means by which Toxoplasma tachyzoites manipulate the host.
The existence of naturally occurring HMA+ and HMA2 strains of Toxoplasma, Legionella, and Chlamydia indicates the
existence of evolutionary niches where HMA is either advantageous or disadvantageous, likely reflecting tradeoffs in
metabolism, immune regulation, and other functions of mitochondria.
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Introduction
Mitochondria are highly dynamic organelles that, besides
producing energy and regulating apoptotic and Ca2+ signals,
play a key role in orchestrating several aspects of cell function
and behavior including autophagy, apoptosis, and immune
signaling [1–3]. Interestingly, recent evidence indicates that
mitochondrial dynamics, including distribution, size, and
shape, are linked to altered regulation of certain innate
immune responses [4,5].
Given this diversity of function, it is no surprise that
mitochondria have recently emerged as central to host–pathogen
interactions, with an increasing number of viruses and bacteria
having been shown to manipulate host mitochondria in their roles
in apoptosis, energy production, and immune function. For
example, the hepatitis C virus protease NS3/4a cleaves the N-
terminal fragment of the mitochondrial antiviral signaling protein
(MAVS), rendering infected cells unable to induce interferon (IFN)
production [6], and Helicobacter pylori vacuolating cytotoxin (VacA)
engages the machinery involved in regulation of mitochondrial
fission to induce apoptosis [7].
In light of these newly established roles for mitochondria and
their targeting by different microbial effector proteins, it is
interesting that during infection with certain pathogens host
mitochondria associate with and appear sequestered at the vacuole
in which the microbes reside. This phenomenon has been
previously reported during infection with the bacteria Legionella
pneumophila [8] and Chlamydia psittaci [9] and the parasite Toxoplasma
gondii [10], and this occurs both in mammalian (T. gondii, L.
pneumophila, and C. psittaci) and protozoan host cells (L. pneumophila
in Hartmannella vermiforis [11]). Although the mechanism and
functional consequence of this association during infection with
these bacteria remain unknown, it has been reported that this
association is species-specific [9]—for example, C. psittaci, but not
Chlamydia trachomatis, intimately associates with mitochondria. In
the case of T. gondii, three predominant, clonal lineages have been
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described based on genotyping performed on isolates from human
and animal infections in North America and Europe [12].
Referred to as type I, type II, and type III, these lineages differ
widely in a number of phenotypes including migratory capacity
[13], cytokine production in infected cells [14,15], and virulence in
mice [16]. Whether these lineages also differ in their ability to
recruit host mitochondria, however, has not previously been
assessed.
Since the initial discovery of host mitochondrial association
(HMA) in macrophages infected with (type I) Toxoplasma
tachyzoites in 1972 [10], the question of what parasite factor
mediates this association has been of intense interest. Previous
work suggested that Toxoplasma HMA was mediated by Toxoplasma
rhoptry protein 2 (ROP2) [17]. However, subsequent work
showed that parasites lacking ROP2 expression were indistin-
guishable from wild-type parasites in their ability to recruit host
mitochondria, reopening the question of what factors mediated the
association [18]. The functional significance of the recruitment of
mitochondria to the Toxoplasma vacuole also remained a conun-
drum. Although HMA has long been assumed to reflect a crucial
means by which the parasite acquires key metabolites, only limited
evidence has emerged to support this hypothesis [19,20]. Given
our expanded understanding of the diverse roles performed by
mitochondria, however, we hypothesized that HMA confers a
selective advantage to the various infectious agents where it has
been described and that mitochondrial functions other than
metabolism might also contribute to this advantage.
Here, we report that HMA is strain-specific in Toxoplasma and
that it is mediated by a novel, secreted parasite factor,
mitochondrial association factor 1 (MAF1), which differs in
sequence, gene copy number, and expression between the three
canonical strains. We demonstrate that MAF1 is necessary and
sufficient for HMA and go on to show that during Toxoplasma
infection, HMA is associated, in vitro and in vivo, with substantially
altered levels of cytokines. These results demonstrate that HMA is
an additional means by which Toxoplasma tachyzoites interface
with the immune signaling of the host and suggest that, in addition
to possible metabolic roles, HMA may present a novel strategy for
subversion of host immune signaling by a pathogen.
Results
Toxoplasma Association with Host Mitochondria Is Strain-
Specific
Given that the three predominant strains of Toxoplasma differ
widely in a number of immune-related phenotypes [21] and that
mitochondria have recently been shown to play a key role in
orchestrating the cellular immune response to viral infection
[22,23], we hypothesized that HMA might differ between these
canonical strains. To investigate this possibility, human foreskin
fibroblasts (HFFs) were labeled with MitoTracker and infected
with representative type I (RH), type II (Me49), or type III (CEP)
strains of T. gondii. At 4 h postinfection (hpi), the type I and III
tachyzoites showed the canonical, intimate, and extensive associ-
ation of host mitochondria at the parasitophorous vacuole
membrane (PVM)–host interface, whereas type II parasites
showed little if any HMA (Figure 1A–C). To quantify and expand
on these findings, the percentage of the PVM associated with host
cell mitochondria was measured in electron micrographs of HFFs
4 hpi with type I, II, and III parasites (Figure 1D–F). The results
showed that ,35% and ,18% of the PVM is tightly associated
with host cell mitochondria in type I and III strains, respectively,
in contrast to ,2% of the PVM in infections with type II parasites
(Figure 1G). Although host endoplasmic reticulum (ER) has also
been reported to associate with the PVM [24], the abundance and
size of the ER meant we were unable to confidently assess or
quantify such association and so cannot comment on which strains
of Toxoplasma do or do not exhibit this trait.
To ensure the generality of the HMA2 phenotype in type II
strains, HMA was also assessed in an independent type II strain,
Pru, which was isolated in France (Me49 was isolated in the
United States of America); Pru was also found to be HMA2
(Figure S1), demonstrating that the HMA2 phenotype is not an
isolate-specific property of Me49. Similarly, to determine whether
HMA differed among cell lines of different mammalian and tissue
origins, we tested the phenotype in murine macrophages and
Madin–Darby canine kidney cells and obtained the same results as
in the HFFs: type II was consistently HMA2, whereas types I and
III were HMA+ (unpublished data). To determine if HMA occurs
during in vivo infection, peritoneal exudate cells (PECs) were
isolated from mice infected with type I and type II parasites and
processed for electron microscopy analysis. Quantification of
HMA in infected PECs (Figure S2) confirmed that HMA occurs in
animals infected with type I but not type II strains. These results
show that recruitment of host mitochondria to the Toxoplasma
PVM is a strain-specific property of Toxoplasma in vitro as well as
in vivo.
HMA Phenotype Maps to Toxoplasma Chromosome II
Previous work has utilized genetic crosses between the canonical
Toxoplasma lineages to map the loci responsible for major
phenotypic differences [25]. We sought to test our hypothesis that
strain-specific HMA had a genetic basis by utilizing F1 progeny
from a type II6III cross [26], as these lineages differ in their ability
to recruit mitochondria and their progeny have been previously
genotyped at 135 different markers [27].
To facilitate HMA screening in the F1 progeny, we first
determined whether co-infection with an HMA2 strain and
HMA+ strain could alter the HMA phenotype of either parasite.
The results showed that co-infection of HFFs with strains that
differ in HMA did not affect the phenotype: type II parasites were
Author Summary
Recent discoveries have revealed the remarkable function-
al diversity of mitochondria in roles other than energy
production, including an integral role for mitochondria
and their dynamics in the regulation of the innate immune
response. Interestingly, host mitochondria are recruited to
the membranes that surround certain intracellular bacteria
and parasites during infection. To date, how and why this
phenomenon occurs has been a mystery, although it has
been proposed to provide a metabolic benefit to the
microbes. Here we identify mitochondrial association
factor 1 (MAF1) as the parasite protein that mediates the
association between the protozoan pathogen Toxoplasma
and host mitochondria during infection. We show that
MAF1 is needed to recruit host mitochondria to the
Toxoplasma-containing vacuole and that this process is
associated with changes in the immune response in
infected cells and animals. These findings show that
recruitment and association with host mitochondria is an
important means by which intracellular pathogens inter-
face with their host. We also find that the cost–benefit
outcome of altering mitochondrial function might differ
between strains depending on the precise niche in which
they evolved; for infectious agents, these differences likely
reflect different host organisms.
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within HMA2 vacuoles, whereas types I and III showed efficient
HMA (Figure S3). To reliably determine the HMA phenotype of
the F1 progeny, therefore, HFFs were co-infected with each of the
34 F1 progeny and a GFP expressing HMA
+ control. This allowed
for a direct comparison and qualitative assessment of the HMA
phenotype between each progeny and the HMA+ control within
the same cell. In all, 15 progeny were HMA2, 18 were HMA+,
and one was indeterminate; example HMA+ and HMA2 progeny
are shown in Figure 2A and Figure 2B, respectively. To identify
the genomic region(s) mediating HMA, we searched for associa-
tion between the previously mapped Toxoplasma genetic markers
[27] and the HMA phenotype and found a highly significant co-
segregation between HMA and chromosome II (LOD ,6.3; p,
0.001, Figure 2C); only F1 progeny having type III alleles at
chromosome II were HMA+ (Figure S4). To refine the preliminary
mapping, we analyzed the genotypes of two progeny with
recombinations on chromosome II, E7 and STG2 (Figure S4,
boxed region), which indicated that the region containing the
parasite factor that mediates HMA is in the interval between the
left end of chromosome II and marker KT-L379A, a maximum
size of ,1.2 Mb.
TGGT1_053770 Is a Novel Secreted Toxoplasma Protein
and Candidate Mediator of HMA
To choose among the list of 153 genes present in the region
identified on chromosome II as possibly involved in HMA, we used
a candidate gene approach based on properties predicted for the
parasite factor. HMA occurs at the PVM and is strain-specific; thus,
we used bioinformatics to first identify genes that encoded a
predicted signal peptide and a transmembrane (TM) domain, and
had different expression levels between HMA+ (types I and III) and
HMA2 (type II) strains. Of the 10 genes that fulfilled these criteria,
the type I gene TGGT1_053770 (denoted in ToxoDB v7.2; as
TGME49_020950 in type II and TGVEG_051550 in type III;
Figure 3A) stood out as the most promising for multiple reasons: (1)
This gene had been previously identified in proteomic studies as a
secreted Toxoplasma antigen [28], suggesting that it was capable of
interacting with the host cell; (2) microarray data for 17 of the
progeny phenotyped for HMA showed that this transcript was of
generally higher abundance in the 9 F1 progeny that were HMA
+
relative to the 8 F1 progeny that were HMA
2 (Figure 3B) [29]; (3)
we had also observed in prior studies that the protein encoded by
TGGT1_053770 is heavily phosphorylated in infected cells relative
to extracellular parasites [30], a further indication that it might be
secreted into the PV or host cell, and we confirmed postinvasion
phosphorylation of TGGT1_053770 by comparing electrophoretic
migration after addition of phosphatase in intracellular and
extracellular parasite lysates (Figure 3C); and (4) lastly, as with
Toxoplasma ROP5, which is crucial for type I virulence in mice [31],
there is precedent for gene family expansions playing a key role in
interfacing with host immune defenses [32,33] and determining
pathogen host range [34]. The TGGT1_053770 locus is expanded
in T. gondii: based on raw genomic sequence coverage, type I (GT1)
has ,6–10 copies, whereas types II (ME49) and III (VEG) have
,4–5 copies (Figure 3D).
To determine if the protein encoded by TGGT1_053770 traffics
to the PVM, a property expected of a protein mediating HMA,
HFFs were infected with type I parasites engineered to ectopically
Figure 1. HMA in Toxoplasma-infected cells is strain-specific. (A–C) HFFs were labeled for 30 min at 37uC with 50 nM MitoTracker and then
infected with (A) type I (RH), (B) type II (ME49), or (C) type III (CEP) strains of T. gondii. Cells were fixed 4 hpi and visualized by fluorescence microscopy.
Phase, fluorescence (MitoTracker), and merged images are shown for each type. Scale bar, 5 mm. (D–F) Transmission electron micrographs depicting
the PVM surrounding (D) type I, (E) type II, and (F) type III parasites grown in HFFs. Cells were fixed and processed for electron microscopy 4 hpi. Host
mitochondria are indicated by M and parasites by P. (G) Percentage of the PVM associated with mitochondria in type I, II, and III vacuoles as
determined by ImageJ analysis of electron micrographs (n=20 for each). Values shown are mean 6 SEM. ****p,0.0001 using an unpaired t test.
doi:10.1371/journal.pbio.1001845.g001
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express an N-terminally HA-tagged version of the protein driven
by its own promoter and with the HA-tag placed just downstream
of the putative signal peptide. Using anti-HA antibody, the tagged
protein was indeed found to localize at the PVM (Figure 3E). This
localization was confirmed by raising antibodies to recombinant
TGGT1_053770 and showing that these antibodies likewise
stained the PVM of cells infected with type I parasites
(Figure 3F). There was near-perfect co-localization of the anti-
HA antibodies and anti-TGGT1_053770 antibodies in cells
infected with type I parasites expressing TGGT1_053770, showing
that the N-terminal tagging did not detectably alter the protein’s
trafficking in the infected cells (unpublished data). Given that the
PVM and intracellular staining pattern was consistent with that of
a dense granular protein, we also looked with antibodies to dense
granule protein 7 (GRA7) and anti-HA antibodies and found that
there was co-localization between these two proteins in extracel-
lular parasites expressing the TGGT1_053770 transgene
(Figure 3H); hence, TGGT_053770 appears to encode a dense
granule protein.
To compare expression of this locus between the archetypal
strains, Western blot analysis of extracellular lysates of type I, II,
and III tachyzoites was performed using anti-TGGT1_053770
Figure 2. HMA phenotype maps to Toxoplasma chromosome II. HFFs were labeled with MitoTracker and then co-infected with a type I GFP+
strain (arrows) and either of two nonfluorescent F1 progeny (white arrowheads), (A) STG2 (F1A, top panel) and (B) E7 (F1B, bottom panel). Cells were
fixed 4 hpi and visualized by fluorescence microscopy. Phase and green fluorescence (GFP) are shown in the first image of each panel. Next to that is
the red fluorescence (MitoTracker) followed by a merged image of the two. Scale bar, 5 mm. (C) LOD Score plot indicates the log-likelihood of
association of HMA with markers across the entire Toxoplasma genome in numerical chromosome order.
doi:10.1371/journal.pbio.1001845.g002
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Figure 3. TGGT1_053770 is a novel secreted Toxoplasma protein and candidate mediator of HMA. (A) Schematic diagram of the
TGGT1_053770 protein. Signal peptide (SP), TM domain, and phosphorylation sites (P sites) are indicated where predicted by SignalP 4.0 (http://www.
cbs.dtu.dk/services/SignalP/), TMHMM v. 2.0 (http://www.cbs.dtu.dk/services/TMHMM/), and ToxoDB (www.toxodb.org). (B) Microarray expression
values (log2 ratios of sample intensity over control intensity) for 17 of the HMA-phenotyped progeny (black data points). Red, green, and blue data
points represent expression values for type I (RH; HMA+), II (PDS; HMA2), and III (CTG; HMA+) strains, respectively. Data shown are averages across 10
probes on the cDNA expression array that map to the MAF1 locus. (C) Lysates from extracellular type I parasites and type I–infected HFFs
(intracellular) were treated with and without CIP and loaded in each lane. The membrane was probed with anti-HA antibody conjugated to
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antibodies. The results showed that although expression levels
were comparable in HMA+ type I and III parasites (albeit the type
III protein migrates slightly but reproducibly more slowly), type II
parasites showed no detectable expression (Figure 3G), consistent
with the microarray data in Figure 3D. To determine if this failure
to detect a signal in lysates from type II parasites might be due to a
gross difference between the allele in this strain relative to
TGGT1_053770, we PCR-amplified and sequenced the locus
from RH (type I) and Me49 (type II) genomic DNA. Although the
tandem duplications of this locus make it difficult to determine the
true extent of sequence variation within and between strains, the
results showed a 94.5% predicted amino acid identity between the
two types (Figure S5), making it very unlikely that polyclonal
antisera raised to one would not react with the other.
Collectively, the data above indicate that TGGT1_053770 has
the expected properties of a parasite mediator of HMA in being a
tandemly repeated locus that differs in sequence, copy number,
and expression between strains and that encodes a novel dense
granule phosphoprotein found at the PVM.
TGGT1_053770 (MAF1) Mediates Toxoplasma HMA
To directly test the hypothesis that TGGT1_053770 mediates
HMA, we infected HFFs with type II parasites or type II parasites
engineered to express the N-terminally HA-tagged type I allele of
this gene (referred to here as type II:MAF1). At 12 hpi, cells were
fixed and stained with anti-TGGT1_053770 polyclonal sera along
with antibodies to Translocase of the Outer Membrane 20
(TOM20), a marker of host mitochondria. The results (Figure 4A)
showed that expression of TGGT1_053770 in type II tachyzoites
is associated with a dramatic gain in HMA, with the recruited
mitochondria being specifically associated with the portions of the
PVM that stained with anti-TGGT1_053770. Electron microsco-
py (Figure 4B) confirmed that the HMA+ phenotype of type
II:TGGT1_053770 parasites results in a marked increase in the
levels of mitochondrial recruitment; on average, ,30% of the
PVM surface appears associated with host mitochondria when
infecting with these parasites compared to ,2% with type II
parasites (Figure 4C). The results above show that TGGT1_053770
encodes a novel protein that is sufficient for recruitment of host
mitochondria to the vacuole containing type II Toxoplasma
parasites and confirm the role of TGGT1_053770 in mediating
HMA. We will hereafter refer to TGGT1_053770 as MAF1.
To further explore the role of MAF1 in HMA, type I parasites
lacking MAF1 were generated (Dmaf1) and verified as deleted for
MAF1 via PCR, Western blot analysis, and microscopy (Figure
S6). Co-infection experiments using type I and type I:Dmaf1
parasites showed the predicted HMA dependency on MAF1
(Figure 4D); type I parasites exhibit HMA in contrast to the clear
loss of HMA in type I:Dmaf1 parasites. Electron microscopy
(Figure 4E) was used to quantify the difference in HMA: only
,3% of the PVMs surrounding type I:Dmaf1 were associated with
host mitochondria, in contrast to ,35% for type I PVMs
(Figure 4C). These results indicate that MAF1 is necessary for
HMA during type I infection.
We next sought to investigate whether MAF1 is directly
responsible for HMA or whether a parasite partner protein is
involved. To do this, we imaged mouse embryonic fibroblasts
(MEFs) retrovirally transfected with an expression construct
encoding N-terminally HA-tagged MAF1. IFA analysis of a
transfected population showed a clear co-localization of MAF1
with TOM20, a mitochondrial membrane marker (Figure 5A),
indicating that MAF1 is directly responsible for HMA.
Exposure of the C-Terminus of MAF1 Is Essential for Its
Role in HMA
Although BLAST searches yielded no clues as to the coding
function or region of MAF1 responsible for HMA, we hypothe-
sized that during Toxoplasma infection the predicted TM domain
anchors MAF1 at the PVM, allowing for the MAF1 C-terminal
domain to be exposed to the host cell cytosol, where it tethers host
mitochondria. To test this hypothesis, type II parasites were
engineered to express MAF1 bearing a C-terminal HA epitope tag
(MAF1_CHA). The HA tag served a dual purpose: to allow for
recognition of the expressed transgene as well as function as a
steric block if an exposed C-terminus is necessary for HMA. The
results showed that the type II:MAF1_CHA parasites remain
HMA2, suggesting a native C-terminus is necessary for MAF1
function (unpublished data). Surprisingly, in type I parasites
engineered to express MAF1_CHA, the C-terminally HA-tagged
MAF1 acts as a dominant negative; its expression results in a
dramatic loss of HMA at 4 hpi even though it correctly localizes to
the PVM (Figure 5B and C). These data suggest that the C-
terminal domain of MAF1 is key to its role in HMA, although we
cannot exclude an indirect effect of the C-terminal epitope tag.
MAF1 Induces Changes in Mitochondrial Morphology
and Is Associated with an Altered Host Cell Response to
Toxoplasma
The identification of MAF1 as the molecule that Toxoplasma uses
to mediate HMA enabled us to next address the functional
consequences of HMA in the host–pathogen interaction. HMA
has been hypothesized to serve as a source of metabolites for the
parasite, and previous work has shown that Toxoplasma scavenges
host-derived mitochondrial lipoic acid [19]. To determine the role
of HMA during tachyzoite growth within a host cell, type I versus
type I:Dmaf1 proliferation was compared in a competitive growth
assay in HFFs in vitro. At 7–10 d postinfection (dpi), we observed
no significant growth disadvantage in type I:Dmaf1 parasites due to
the loss of HMA. A similar comparison of growth of type II versus
type II:MAF1 parasites also yielded no reproducible change in
their relative numbers 7–10 dpi (unpublished data). Collectively,
these data support the conclusion that HMA does not result in
growth differences between type I and type II parasites in a
nutritionally replete environment, although this does not exclude a
metabolic role for HMA.
As previously mentioned, HMA occurs during infection with the
vacuolar pathogens C. psittaci and L. pneumophila. To address the
peroxidase. (D) Normalized sequence coverage (y-axis) reflective of the number of copies of TGGT1_053770 on chromosome II (x-axis) for types I
(GT1), II (ME49), and III (VEG). The region putatively encoding TGGT1_053770 is indicated by a black bar. (E) Type I parasites expressing HA-tagged
TGGT1_053770 were added to HFFs, and cultures were fixed 6 hpi. Following permeabilization, TGGT1_053770 was visualized using anti-HA
antibodies. Scale bar, 5 mm. (F) Type I parasites were added to HFFs, and cultures were fixed 6 hpi. Following permeabilization, TGGT1_053770 was
visualized using polyclonal anti-TGGT1_053770 mouse sera. Scale bar, 5 mm. (G) Western blot showing expression of TGGT1_053770 in type I, II, III
and type II parasites. Blots were probed with antibodies to recombinant TGGT1_053770 (upper panels), then probed for surface antigen SAG1 as a
loading control (lower panels); white vertical lines indicate that the order of the lanes shown is different from the original loading of the gel. Note that
the product of the type III allele has a reproducibly slower electrophoretic mobility than type I. (H) Syringe-lysed parasites were plated on coverslips
and fixed, labeled with anti-HA (TGGT1_053770) and anti-GRA7 antibodies, and visualized using confocal microscopy.
doi:10.1371/journal.pbio.1001845.g003
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consideration that HMA represents a conserved host response to
vacuolar pathogens and might be the result of toll-like receptor
(TLR) or IFN-dependent signaling, we infected bone marrow
isolated from MyD882/2, IFNAR2/2, and wild-type mice with
type I and type II parasites (MyD88 is a common part of the
signaling pathway for many TLRs, and IFNAR is the shared
receptor used by type I IFNs). Electron microscopy showed no
differences in HMA in these mutant bone marrow cells relative to
wild-type cells (unpublished data). Given our growing understand-
ing of how different Toxoplasma strains vary in their interaction
with the host, we hypothesized that HMA might be involved in the
strain-specific ability of Toxoplasma to alter innate immune
signaling in infected host cells. Interestingly, early observations
of HMA described the presence of ‘‘giant mitochondria’’ at the
Toxoplasma PVM during infection [35], and more recently, the
proteins that regulate mitochondrial morphology have been found
to play a crucial role in modulating cellular immune signaling
during viral infection [36–38]. To determine if HMA results in
morphological differences in the associated host mitochondria, the
average sizes of unassociated (cytosolic) mitochondria and PVM-
associated mitochondria in mouse bone-marrow-derived macro-
phages (mBMDMs) infected with type I parasites were measured
in electron micrographs. The analysis was also done during type
II:MAF1 infection for confirmation. The results showed that in
mBMDMs infected with type I or type II:MAF1 parasites, the
average cross-sectional area of a PVM-associated mitochondrion is
approximately 3-fold greater than the average for cytosolic
mitochondrion (Figure 6A and B). These changes in morphology
are consistent with the elongation of mitochondria observed
during viral infection [37] and support a general role for
alterations in mitochondrial morphology having an impact in
microbial infection.
Previous work has shown that signaling through the mito-
chondrion can alter transcription of proinflammatory cytokines
[39]. To investigate the role of HMA in the immune response to
Toxoplasma, microarrays were used to compare the transcriptional
profiles of MEFs 8 hpi with type II and type II:MAF1 parasites.
The microarray analysis revealed that the expression of several
chemokines and IFN-gamma-induced genes differed significantly
in a MAF1-dependent manner (Figure 6C) and that three of the
greatest transcriptional changes were seen for the proinflamma-
tory cytokines CXCL2, CSF2, and IL6, with respective increases
in expression in the type II:MAF1–infected cells of ,4.6-, 4.8-,
and 5-fold. Using Gene Set Enrichment Analysis (GSEA), we
found that canonical immune pathways, including JAK-STAT,
NFAT, and IL10, were among the most significantly enriched
gene sets up-regulated during type II:MAF1 infection relative to
type II wild type (Figure S7). Although we cannot exclude the
possibility that MAF1 mediates these effects independent of its
role in HMA, these data suggest that HMA in type II parasites
has a significant impact on the host cell’s transcriptional
response to Toxoplasma, especially in terms of innate immune
signaling.
To explore this issue further, levels of 26 cytokines,
chemokines, and growth factors were measured from superna-
tants of mBMDMs 3 hpi and 17 hpi with type II and type
II:MAF1 parasites using the Luminex Mouse 26-plex (Meso Scale
Discovery, services rendered by Stanford Human Immune
Monitoring Center). mBMDMs were used because monocytes
have been shown to account for approximately 60% of infected
Figure 4. MAF1 (TGGT1_053770) mediates Toxoplasma HMA. (A)
Type II or type II parasites expressing an N-terminally HA-tagged
TGGT1_053770 transgene were used to infect HFFs. Cells were fixed 12
hpi, and following permeabilization, TGGT1_053770 was visualized by
immunofluorescence microscopy using polyclonal mouse sera raised
against recombinant TGGT1_053770; host mitochondria were visualized
using rabbit anti-TOM20 antibodies. (B) Transmission electron micrographs
depicting the PVM surrounding type II and type II:TGGT1_053770 parasites
grown in mBMDMs. Cells were fixed and processed for electron microscopy
6 hpi. Host mitochondria are indicated by M. (C) Percentage of the PVM
associatedwithmitochondria in HFFs 4 hpi with type I and type I:Dmaf1, and
BMMs 17 hpi with type II and type II:MAF1 vacuoles as determined by
ImageJ analysis of electron micrographs (n=20 for each). Values shown are
mean 6 SEM. ****p,0.0001 using an unpaired t test. (D) Type I and type
I:Dmaf1 parasites (expressing RFP) were used to infect HFFs, which were
then fixed 4 hpi. Following permeabilization, host mitochondria were
visualized using rabbit anti-TOM20 antibodies. (E) Transmission electron
micrographs depicting the PVM surrounding type I and type I:Dmaf1
parasites grown in HFFs. Cells were fixed and processed for electron
microscopy 4 hpi. Host mitochondria indicated by M. Scale bars are 5 mm (A
and C) and 0.5 mm (B and D).
doi:10.1371/journal.pbio.1001845.g004
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cells during a peritoneal infection with Toxoplasma and are
required for immunity to this parasite [40]. At 3 hpi, no
significant differences were seen between type II and type
II:MAF1–infected mBMDMs (unpublished data), whereas at 17
hpi, we observed increased secretion of IL6 and IL10 and the
proinflammatory chemokines RANTES (CCL5) and the murine
IL-8 homologue KC (CXCL1) in cells infected with type II:MAF1
(Figure 6D). Together, these results argue for a key role for
HMA in modulation of the innate immune response during
infection.
Figure 5. Exposure of the MAF1 C-terminus is essential for its role in HMA. (A) MEFs retrovirally transduced for expression of MAF1 were
fixed, and following permeabilization, MAF1 was visualized by immunofluorescence microscopy using HA antibody, and host mitochondria were
visualized using rabbit anti-TOM20 antibodies. Red arrowheads indicate MEFs expressing the transgene. Scale bar, 5 mm. (B) HFFs were co-infected
with type I (white arrowhead) and type I parasites expressing C-terminally HA-tagged MAF1 (MAF1_CHA; green arrowhead) and fixed 4 hpi. Following
permeabilization, MAF1 was visualized using anti-HA antibodies and mitochondria using anti-TOM20 antibody. Scale bar, 5 mm. (C) Percentage of
PVM associated with mitochondria in HFFs 4 hpi with type I:MAF1 and type I:MAF1_CHA as determined by ImageJ analysis of electron micrographs
(n=23 for each). Values shown are mean 6 SEM. ****p,0.0001.
doi:10.1371/journal.pbio.1001845.g005
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Figure 6. MAF1 induces changes in mitochondrial morphology and is associated with an altered host cell response to Toxoplasma.
(A) Transmission electron micrograph of a mBMDM infected 17 hpi with type II:MAF1 parasites. Cells were fixed and processed for electron
microscopy. Scale bar, 0.5 mm. (B) Cross-sectional area of cytosolic and PVM-associated mitochondria during type I and type II:MAF1 infection as
determined by EM analysis (n=20 for each). Values are mean 6 SEM. ****p,0.0001. (C) MEFs were mock-infected or infected with type II or type
II:MAF1 Toxoplasma strains at an MOI of 5. Then, 8 hpi, RNA was isolated from the cultures and analyzed using the Affymetrix Mouse 430 2.0 chip.
Genes whose expression increased at least 2-fold during type II:MAF1 infection relative to type II and were statistically significant at an FDR ,5% for
differential expression using SAM [67] are depicted. Colors indicate the deviation of each gene’s signal above (yellow) and below (blue) its mean
expression value across all six samples. (D) Primary mBMDMs were infected with type II, type II:MAF1 strains, or mock-infected. Supernatants were
collected at 17 hpi, passed through a 5 mm filter, and stored at 280uC. Samples were thawed on ice immediately prior to processing on the Luminex
mouse 26plex (Millipore, USA) platform. Data shown are for the four cytokines with a MAF1-dependent difference and from three biological replicates
(different days) 6 s.e.m. Asterisks denote significant differences between mBMDM cells infected with type II versus type II:MAF1, *p,0.05, ***p,
0.001, ****p,0.0001 using a two-factor ANOVA analysis.
doi:10.1371/journal.pbio.1001845.g006
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Loss of HMA Is Associated with Serum Cytokine Changes
in Vivo
We and others have previously shown that type I parasites
generate a profoundly different immunological response compared
with type II parasites, which activate NF-kB and result in
increased IL-12 production [14,15,41,42]. To avoid the possibility
that the impact of type II on other immune pathways might
interfere with our interpretation of the results, we addressed
whether the loss of HMA in its natural context (type I background)
impacted infection in vitro and in vivo. To test this, WT MEFs were
infected with type I and type I:Dmaf1 parasites, and at 8 hpi, the
RNA was isolated and processed for microarray analysis.
Interestingly, unlike the 231 genes differentially regulated between
type II:MAF1 and type II infection, only eight genes were observed
to be significantly induced in a MAF1-dependent manner during
type I infection, including SerpinB2 and IL-11 (Figure S8); the
increased expression of SerpinB2 and IL-11 receptor alpha (IL-
11rap) was also MAF1-dependent during type II:MAF1 infection
(Figure 6C) and might represent part of a HMA-induced signaling
pathway in host cells.
To address whether the loss of HMA in the type I background
impacted virulence in the murine host, we compared lethality
following intraperitoneal infection of C57/BL6 mice with type I
and type I:Dmaf1 tachyzoites and observed no differences
(Figure 7A). This was expected, as previous analyses of the same
II6III F1 progeny used to map HMA, as well as crosses of type I
with types II and III, showed no indication of a significant mouse-
virulence trait on chromosome II, the MAF1-encoding chromo-
some [43–45]. Although our results confirm that MAF1 is not a
major virulence determinant using the crude measure of mortality
by intraperitoneal infection in mice, they did not address the
possibility of other differences in the host response to infection by
type I and type I:Dmaf1 parasites. To test for such effects, PECs
were isolated from mice 5 dpi with type I or type I:Dmaf1
tachyzoites and their cytokine production assessed on the Luminex
platform at 6 h and 12 h postisolation. The results showed
differences (p,0.05) in two cytokines, IL4 and eotaxin, and
interestingly, both were present at lower levels in cultured
supernatant of PECs from the type I:Dmaf1–infected mice
compared to mice infected with type I (Figure 7B) parasites. To
test the effect on the animal as a whole, sera from similarly infected
mice were also analyzed 5 dpi. We observed that, as with IL4 and
eotaxin secretion from isolated PECs, 14 of the 26 cytokines
examined were present at lower levels in mice infected with type
I:Dmaf1 relative to type I parasites (Figure 7C). These differences
included IL6, IL10, and RANTES (CCL5), which were increased
in a MAF1-dependent manner during type II versus type II:MAF1
infections in mBMDMs (Figure 5D). To determine if the
differential cytokine production observed was a result of differ-
ences in parasite burden, mice were infected with RFP-expressing
type I and type I:Dmaf1 tachyzoites. At 5 dpi, the same time point
used for the sera analyses, PECs were isolated and analyzed for
RFP expression using flow cytometry and shown to exhibit
comparable parasite levels (Figure 7D). Thus, although the MAF1
genotype appears to have no effect on lethality or parasite burden
during the acute stages of an i.p. infection, these results suggest
some role for MAF1 in modulating the immune response and
support for the notion that HMA is a novel strategy by which an
intracellular pathogen can interfere with host signaling.
Discussion
We have identified the parasite effector that mediates strain-
specific HMA during infection with certain types of T. gondii and
have shown that expression of this effector also impacts the host
immune response. Our findings suggest a new dimension to the
recently discovered role for mitochondria in the innate immune
response [46] and suggest a novel approach by which a microbe
may manipulate host cell processes, be they metabolic or immune
in nature.
Recruitment of Host Mitochondria Is Strain-Specific
It is well known that the three archetypal T. gondii strains that
dominate in Europe and North America differ in several
important host interactions including the ability to inactivate
mouse immunity-related GTPases (IRGs) that otherwise attack the
PVM [47] and to phosphorylate host signal-transducers and
activators of transcription (STATs) [48,49]. We show that HMA is
yet another dramatic way in which the three dominant genotypes
differ and so is part of a complicated calculus in the parasite’s
evolution with the optimal solution (HMA+ or HMA2) likely
depending on the interplay with other factors. For example, it
could be that there are strain-specific differences in the need for
host metabolites produced by the mitochondria (e.g., lipoic acid
[19]) and/or susceptibility to the damage mitochondrial metab-
olites can cause (e.g., reactive oxygen species [50]). Of note, type II
strains but not types I and III encode a version of the soluble
factor, GRA15, that stimulates NF-kB production in infected cells
[14]. It may be that a combination of HMA and NF-kB
stimulation would be suboptimal to the parasite compared to
either on its own, but the extraordinary success of type II in certain
regions of the world clearly indicates that this strain is well
optimized for at least some niche. It is also possible that the
function served by HMA in types I and III is provided by a
completely different mechanism in type II, but until that function
is known, this is difficult to speculate about.
Most models predict that different traits evolved in certain
Toxoplasma strains because of their interaction with a particular
host species or host state. IRGs, for example, are crucial parts of
the immune armamentarium in mice but are functionally lacking
in primates, possibly explaining the polymorphisms seen in the
Toxoplasma effectors, ROP5 and ROP18, that neutralize them.
MAF1, like ROP5 or ROP18, may have evolved as a crucial
defense to the immune response in a specific host. We note that
the dramatic difference in murine fibroblast transcription observed
in type II:MAF1 versus type II infection was not observed in type I
versus type I:Dmaf1 infection. This is likely due to the very different
host responses seen in cells infected with type I versus type II
parasites. We saw no difference in HMA in the three species of
host cells examined (human, mouse, and dog), but we cannot
exclude that some untested host exists where type II tachyzoites do
show HMA, although this would likely require host-specific
activation of transcription from the MAF1 locus given that
MAF1 expression in type II parasites is essentially quiescent when
grown in vitro.
The genes responsible for the HMA seen during Legionella and
Chlamydia infection have not yet been identified, but no MAF1
homologue is seen in their respective genomes by BLAST analysis
(unpublished data). Interestingly, HMA is not seen with all species
of these two genera: L. pneumophila and C. psittaci induce the
phenomenon, but Legionella micdadei and C. trachomatis do not
[9,51], suggesting the presence of a particular niche occupied by
the HMA-inducing species of these bacteria where the phenom-
enon is advantageous. Although it seems likely that HMA is an
example of convergent evolution in these bacteria and Toxoplasma,
the biological implications of HMA in these bacteria will be
difficult to dissect until HMA+ and HMA2 versions are engineered
in the same genetic background.
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MAF1 Is a Novel Example of a Microbial Factor That
Recruits Host Organelles
Although these results demonstrate that MAF1 directly binds
host mitochondria and is crucial for HMA, they do not make any
prediction as to the mitochondrial binding partner and whether
HMA is directly responsible for the observed alterations in the
morphology of the associated mitochondria. No other molecule
has been described with the ability to mediate HMA, and the
sequence of MAF1 did not provide any obvious clues to
mechanism. Previous models involving ROP2 as the mediator of
HMA proposed that a mitochondrial import signal on the
protein’s N-terminus is recognized by the import machinery on
the mitochondria, and an incomplete, stalled uptake of the protein
results in HMA. This exact mechanism seems unlikely given that
the MAF1 C-terminus appears to play a key role, as seen by the
inability of the MAF1_CHA construct to mediate HMA, but our
results would be consistent with a model involving uptake of C-
terminal import signals as shown for the yeast DNA helicase
Hmi1P [52]. Further understanding of the mechanism by which
MAF1 mediates HMA will require identification of the host
molecule(s) bound by MAF1.
How Does HMA Result in Changes in the Host Immune
Response?
Mitochondria act as a nexus for a wide range of host cellular
processes and signaling networks including chemotaxis, calcium
signaling, apoptosis, and immune signaling. It has been previously
reported that during Toxoplasma infection, over one-third of all
modulated host proteins are mitochondrial [53,54], a significant
enrichment considering mitochondrial proteins are predicted to
account for only 4.25% of the cell proteome [54]. This is
consistent with HMA having a profound effect on mitochondria
during a Toxoplasma infection, similar to what has been reported
during bacterial and viral infections where substantial changes are
observed in mitochondrial morphology and outer mitochondrial
membrane composition [50,55]. Our results on the increased
cross-sectional area of PVM-associated mitochondria also suggest
HMA affects their physiology, although we have not directly
assessed this in our experiments here.
The identification of the key protein mediating HMA allowed
us to show that this phenomenon is associated with a significant
alteration of transcription of host cell immune genes. We do not
know the mechanism by which HMA results in the transcriptional
Figure 7. Loss of HMA is associated with serum cytokine changes in vivo. (A) C57BL/6 mice (n= 5 per parasite strain) were infected
subcutaneously with 100 type I or type I:Dmaf1 tachyzoites and time to death assessed. (B) Mice (n=4) were infected intraperitoneally with 100
tachyzoites of a type I or a type I:Dmaf1 strain. At 5 dpi, PECs were isolated and supernatants analyzed for cytokine content at 6 and 12 h
postisolation. (C) Sera (n=12 per parasite strain) and (D) PECs (n= 3 per parasite strain) were isolated from mice infected intraperitoneally with 100
tachyzoites of a type I:RFP+ or type I:Dmaf1:RFP+ strain. Values represent the ratio of the average MFI per cytokine in sera of type I/type I:Dmaf1–
infected mice. Results from three independent experiments were pooled and values reported if p,0.05 using an unpaired t test to compare average
MFI values. PECs were permeabilized and labeled with APC/Cy7-conjugated CD11b antibody and processed for FACS analysis.
doi:10.1371/journal.pbio.1001845.g007
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responses or cytokine responses observed, or whether it is directly
responsible for these changes. It is well known, however, that
during viral infection, signaling through MAVS results in
recruitment of cytosolic factors to the outer mitochondrial
membrane; activation of different transcription factors including
NF-kB, IRF3, and IRF7; and subsequent production of type I
IFNs and inflammatory cytokines [39]. Although there was a
significant enrichment for genes with NF-kB binding sites in their
promoters by Transcription Binding Site analysis of the micro-
array data during type II:MAF1 infection of mBMDMs (unpub-
lished data), there was no evidence for IRF3 or IRF7 activation.
Interestingly, although the absence of MAVS did not appear to
affect HMA in type I–infected cells, five of the eight genes whose
induction or repression was MAF1-dependent in MEFs during
type I infection were also MAVS-dependent (Figure S8). These
include SerpinB2 and TSG14 (tumor necrosis factor–inducible
gene 14) but not, however, IL11, suggesting MAVS may play
some role in MAF1-induced immune changes in the host cell.
Although we cannot exclude the possibility that MAF1 is
mediating the observed transcriptional and immune responses
independently of HMA, we hypothesize that type I and III
Toxoplasma co-opt mitochondrial signaling using HMA to
generate a cytokine milieu conducive to parasite survival and
efficient dissemination. Interestingly, the cytokines whose
levels were increased in HMA+ strains during mBMDM
infection in vitro and in PECS ex vivo, including IL6, CCL5,
and IL10, are not those that would be expected to change
based on interference with known mitochondrial signaling
pathways (i.e., MAVS, NF-kB, IRF3/7 [22,23]). These data
suggest that HMA might be functioning through a yet
unidentified pathway linking mitochondria and innate immune
signaling, further highlighting the connection between mito-
chondria and immunity. It is possible that the observed
changes in mitochondrial morphology reflect this manipula-
tion, as it has previously been shown that the machinery that
regulates mitochondrial fission and fusion (e.g., Mitofusin 1
and 2) are also necessary in the signaling cascades that result
during viral infection [37,38]. Future work will be required to
map out the pathways that link HMA to the observed
differences in cytokine responses, as well as to determine
how the consequences of HMA impact the host–parasite
interaction. Our identification of strain-specific differences in
HMA during infection with Toxoplasma and the molecular basis
underlying those differences provides a model that can be used
to dissect the biological role of HMA and the possibly
novel ways by which mitochondria engage immune-signaling
pathways.
Materials and Methods
Parasite and Cell Culture
T. gondii parasites of the type I (RHDhxgprt), type II
(ME49Dhxgprt), and type III (CEPDhxgprt) strains [deleted for the
hypoxanthine–xanthine–guanine phosphoribosyl transferase (HXGPRT)
gene] were maintained by serial passage in HFF monolayers.
The GFP-expressing strain of RH (RHgfpluc) [56] and the F1
recombinant progeny derived from type II (ME49) and type III
(CEP) [57] crosses used for the co-infections have all been
described previously.
mBMDMs were obtained from female C57BL/6 mice as
previously described [14] and cultured in 20% M-CSF, 10% heat-
inactivated FBS, 2 mM L-glutamine, 1 mM sodium pyruvate, 16
DMEM (Dulbecco’s modified Eagle’s medium; Invitrogen) plus
nonessential amino acids, and 50 mg/ml each of penicillin and
streptomycin. MEFs (a gift from Z.J. Chen, University of Texas
Southwestern Medical Center at Dallas) and HFFs were grown in
complete DMEM (cDMEM) supplemented with 2 mM glutamine,
100 U/ml penicillin, and 100 mg/ml streptomycin and 10% heat-
inactivated fetal calf serum (FCS).
Cloning MAF1 Paralogs from Type I and Type II Strain
Parasites
Genomic DNA from either RH88 (type I) or ME49 (type II) was
used as a template in PCR reactions using Platinum Taq HiFi
polymerase (Invitrogen; Life Technologies) with primers 59
AGGGATACGAACAACTCGCTTAT 39 (forward) and 59
GTCCAGCATGCTAGCCAGATACGT 39 (reverse). PCR was
performed under standard conditions, except extension times for
each cycle were carried out for 7 min at 68uC to minimize
chimera formation between different MAF1 copies. PCR products
were gel-purified and cloned into the PCR2.1 Topo vector and
completely sequenced. Inserts ranged in size from 2,995 to
3,119 bp and were spliced in silico based on the annotated splice
sites for TGGT1_053770. Sequences were aligned using ClustalW
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) and visualized us-
ing Jalview.
Generation of Transgenic Parasites
For generation of an N-terminally hemagglutinin (HA)-tagged
MAF1 expression construct (pMAF1), the promoter (,1.5 kb
sequence upstream of the start codon) was cloned into the pGra-
HA_HPT vector [58] at the HindIII and NsiI sites using forward
primer CCAAGCTTCTGCGACGTGATCGTGGCAA and re-
verse primer CCATGCATCGCGTAGTCCGGGACGTCG-
TACGGGTAACCGGCGGTCAG [reverse primer encodes an
HA tag (bolded) fused immediately downstream of the region
encoding the predicted signal peptide]. The coding region
downstream of the signal peptide of MAF1 up to the stop codon
was cloned into the NsiI and PacI sites with forward primer
CCATGCATGGTGGTCTAGGCAGTCAGATGTCGG [in-
troduces two glycine residues (bolded) after the signal peptide]
and reverse primer CCTTAATTAATC AGTCCAGCATGC-
TAGCCAG. Transgenic parasite strains were made by electro-
poration of the parental type I and II T. gondii strains with 20 mg of
linearized pMAF1 and applying mycophenolic acid and xanthine
selection to isolate and clonally expand parasites positive for
HXGPRT expression [59]. Type I strains transfected with pMAF1
are referred to as type I:TGGT1_053770 or type I:MAF1; type II
strains transfected with pMAF1 are referred to as type
II:TGGT1_053770 or type II:MAF1.
A construct for knocking out the endogenous MAF1 locus
(pMAF1LKO) was created from the parental pTKO vector [60].
Briefly, an ,850 bp region of genomic DNA corresponding to
sequences upstream of the TGGT1_053770 start codon (59
homology region or 59 HR) and a ,720 bp region of genomic
DNA corresponding to sequences upstream of TGGT1_ 064860
(39 HR) were cloned into NotI/EcoRV and HpaI/ApaI restriction
sites that flank the T. gondii HXGPRT gene and GRA2 39-UTR in
the pTKO vector, respectively. Primers for amplification of the 59
insert were AAGCGGCCGCCGAGACAGAGAGCAGTGC-
CAA and AAGATATCGGATGTGGCTCCACTGGTGAAT;
for the 39 insert, they were CCGTTAACGTGAGAGCTCCAT-
CATCGACTCCTT and AAGGGCCCGGTGTGCCCGCT-
TGGATCAA. The type I:Dmaf1 parasite strain was made by
electroporating type I (DhxgprtDku80) parasites with 25 mg of
linearized pMAF1KO and selecting for HXGPRT-positive
parasites as previously described [30].
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Immunofluorescence Assay
HFFs were grown to confluency in 24-well plates. For staining
with MitoTracker (Invitrogen), medium was replaced with
prewarmed DMEM containing MitoTracker at a concentration
of 50 nM. After 30 min of incubation at 37uC, cells were washed
and then infected with parasites in prewarmed cDMEM. At 4 hpi,
cells were washed in PBS and fixed in prewarmed cDMEM
containing 3.7% formaldehyde for 15 min. Otherwise, parasites
were allowed to invade confluent HFF monolayers on coverslips
for 6 and 12 h, fixed in 4% formaldehyde, permeabilized with
0.1% Triton-X100 for 20 min, and blocked in PBS supplemented
with 3% BSA. Coverslips were then incubated with 3F10 (anti-
HA) antibody (Roche, Palo Alto, CA), antibodies specific for
TOM20 (SCBT, Santa Cruz, CA), or mouse polyclonal sera to
MAF1 for 1–3 h at room temperature (RT). Fluorescent
secondary antibodies (Invitrogen/Molecular Probes, Carlsbad,
CA) were used for antigen visualization. Coverslips were mounted
in VectaShield (Vector). Phase and fluorescence images were
captured with a Hamamatsu Orca100 CCD on an Olympus
BX60 (1006) and FV1000 Olympus confocal scope (DIC) and
processed using Image-Pro Plus 2.0 (MediaCybernetics).
Western Blot Analysis
For MAF1 immunoblotting, cells were lysed in sodium
dodecylsulfate sample buffer, and samples were resolved on 8%
SDS-polyacrylamide gels and blotted to PVDF membranes
(Millipore, Billerica, MA). Following gel transfer, membranes
were blocked with PBS-0.05% Tween 20 (PBS-T) and 0.05%
nonfat dry milk for an hour and then incubated in mouse anti-
MAF1 sera at 1:250 for 3 h. Following incubation, blots were
washed three times in PBS-T and then incubated with horseradish
peroxidase (HRP)-conjugated anti-mouse antibodies at a 1:2,500
dilution. The membrane was stripped (Invitrogen stripping buffer)
and reprobed with rabbit anti-SAG1 antibody at a 1:100,000
dilution in blocking solution for 1 h. After three PBS-T washes, the
blot was incubated with HRP-conjugated anti-rabbit antibodies at
a 1:3,000 dilution and developed using a chemiluminescence
system (Pierce Chemical Co., Rockford, IL). For assessing
phosphorylation, lysates from extracellular type I parasites and
type I–infected HFFs (intracellular) were treated with and without
calf intestinal phosphatase (CIP) for 1 h and loaded in each lane.
The membrane was probed with anti-HA antibody conjugated to
peroxidase and developed as stated above.
Antibody Generation
Recombinant MAF1 protein (amino acids 134–443) was
expressed with a C-term His-66 tag as previously described [61]
and was a gift of M. Tonkin and M. Boulanger (University of
Victoria). Blood of naı¨ve female Balb/c mice was drawn and tested
against recombinant MAF1I to establish baseline reactivity. Each
mouse was then immunized intraperitoneally (IP) with 0.1 mg of
MAF1 antigen in a 1:1 mixture with RIBI (Corexia) in a final
volume of 200 ml. Three IP injections of 50 mg in a 1:1 mixture
with RIBI (final volume 200 ml) were administered on day 14, 35,
and 56. The final bleed was taken at week 13; collected sera were
verified by IFA and Western blot analysis.
Electron Microscopy
Monolayers of BMMs grown on glass coverslips were synchro-
nously infected with parasites as described above and 6 h later
fixed in Karmovsky’s fixative—2% glutaraldehyde and 4%
paraformaldehyde in 0.1 M sodium cacodylate pH 7.4—for 1 h
at RT. Following this, the cultures were stained with 1% osmium
tetroxide for 1 h at RT, washed 36with ultrafiltered water, then
stained in 1% uranyl acetate overnight. After a series of ethanol
washes and propylene oxide incubations, the samples were placed
into molds with labels and fresh 100% EMbed-812 resin in a 65uC
oven overnight.
Sections were taken between 75 and 90 nm, picked up on
formvar/Carbon coated 75 mesh Cu grids, and stained for 20 s in
1:1 saturated uranyl acetate (7.7%) in acetone followed by staining
in 0.2% lead citrate for 3 to 4 min. Samples were observed in the
JEOL 1400 TEM at 80 kV, and photos were taken using a Gatan
Multiscan 791 digital camera.
For quantification of HMA, 30 images were taken of PVs in
infected cells and 20 (or as indicated) were randomly selected for
further analysis by ImageJ. Image J was used to measure the
percentage of the PVM perimeter closely associated with host
mitochondria (PVM associated with mitochondria/total
PVM6100).
Sequence Read Alignments
Raw sequence reads for T. gondii (strains GT1, ME49, and
VEG) were downloaded from the NCBI trace archive in FASTA
format. Reads were aligned to the T. gondii ME49 genome (version
7.0; ToxoDB) using BLAT with the following parameters: -
fastMap -minIdentity = 95 -minScore = 90 [62]. Following con-
version of the blat output file (psl format) to the SAM format using
the psl2sam.pl script within the Blat distribution, the SAM file was
converted to a sorted BAM file using Samtools [63]. Sequence
coverage was determined in each 500 bp window using cover-
ageBed, distributed with BEDtools [64]. Output was uploaded in
R to generate sequence coverage plots of the expanded locus
encompassing TGGT1_053770 plus 20 Kb of upstream and
downstream sequence. The average read coverage per 500 bp
window in the 20 Kb sequence upstream of the expanded locus
was used to normalize the coverage plots for all three strains.
Retroviral Expression
For generation of MAF1 expression in MEFs, the coding region
for the full-length MAF1 was PCR-amplified from pMAF1 using
the forward primer TTC TCG AGC ACC ATG GCC GGT
TAC CCG TAC GAC G and reverse primer TTG CGG CCG
CTC AGT CCA GCA TGC TAG CCA G and cloned into the
XhoI and NotI sites of the MSCV2.2 vector (gift from the Barton
Lab, University of California, Berkeley) downstream of the CMV
promoter. The forward primers included the Kozak consensus
sequence (CACC) before the start codon. The MAF1 transgene
starts at the signal peptide cleavage site (amino acid 24), has an N-
terminal HA tag after the signal peptide cleavage site, and runs
through to the stop codon. Phoenix cells were transfected with
15 mg of pMSCV_MAF1 using Lipofectamine LTX (Invitrogen).
About 24 hpi transfection, the supernatant was removed and
replaced with fresh cDMEM and the cells transferred to 32uC.
The following day the supernatant was filtered with a 22–45 mm
filter, polybrene at a concentration of 5 mg/ml was added, and the
mix transferred to MEFs at a confluency of 50%. MEFs were
incubated for one day at 32uC and then returned to 37uC for
expansion. Cells were analyzed for MAF1 expression via
immunofluorescence using anti-HA or polyclonal anti-MAF1
antibodies.
Microarrays
For mouse arrays, WT and MAVS2/2 MEFs were grown in a
six-well plate to confluency. Parasite strains were syringe-lysed and
washed once with PBS. MEFs were infected with type I, type
I:Dmaf1, type II expressing luciferase (Me49:LUCDhxgprt), or type
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II:MAF1 parasites at an MOI of 5 or mock-infected for 8 h after
which RNA was isolated using TRIzol (Invitrogen) followed by
labeling and hybridization to a mouse Affymetrix array (Mouse
430A 2.0) according to the manufacturer’s protocol. Probe
intensities were measured with the Affymetrix GeneChip Scanner
3000 7G and were processed into image analysis (.CEL) files with
GeneChip Operating Software (Affymetrix). Data were normal-
ized using the Robust Multi-Array Average normalization
algorithm. GSEA was used to identify canonical pathways and
candidate transcription factors modulated by MAF1 [65,66].
Statistical significance for differential gene expression was deter-
mined using SAM [67]. The delta parameter was adjusted to
achieve a false discovery rate (FDR) nearest to 10%, or as
indicated, and this delta value was used to select significantly
regulated genes. All microarray data have been deposited in the
Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/).
Bone Marrow Macrophage Secretion
Primary mBMDMs were isolated from female B6 mice and
plated to confluency in 24 wells. BMDMs (three wells per
condition) were infected with type II (Me49:LUCDhxgprt) or type
II:MAF1 parasites at an MOI of 3 or mock-infected in equal
volumes. At 3 hpi and 17 hpi, supernatants from the three wells for
each condition were pooled, pushed through a 5 mm filter, and
stored at 280uC until analysis. Supernatants were analyzed in the
Human Immune Monitoring Core (Stanford, CA) by Luminex
Mouse 26-plex kits purchased from Affymetrix and used according
to the manufacturer’s recommendations with modifications as
described below. Briefly, samples were mixed with antibody-linked
polystyrene beads on 96-well filter-bottom plates and incubated at
RT for 2 h followed by overnight incubation at 4uC. Plates were
vacuum-filtered and washed twice with wash buffer, then
incubated with biotinylated detection antibody for 2 h at RT.
Samples were then filtered and washed twice as above and
resuspended in streptavidin-PE. After incubation for 40 min at
RT, two additional vacuum washes were performed, and the
samples resuspended in Reading Buffer. Each sample was
measured in duplicate. Plates were read using a Luminex 200
instrument with a lower bound of 100 beads per sample per
cytokine. Data shown are averaged from three independent
experiments and are from three biological replicates (different
days) 6 s.e.m. Asterisks denote significantly different MFIs
between mBMDM cells infected with type II versus type II:MAF1,
* p,0.05, *** p,0.001, **** p,0.0001 using a two-factor
ANOVA analysis.
PEC Isolation
Euthanized C57BL/6 mice (n= 4 per parasite strain) were
injected with 6 ml cold 16 PBS using a 26 gauge needle. Mice
were palpated for 1–2 min, following which fluid contents were
aspirated out of the peritoneum. Content was spun down at
1,000 rpm for 5 min, washed, and resuspended in DMEM to a
concentration of 26106 per ml. We incubated 500 ml of this
material for 6 or 12 h, passed it through a 0.2 mm filter, and the
filtrate was stored at 280uC until Luminex analysis. Samples were
analyzed for 26 cytokines using the Luminex platform (see above).
Data were reported if p,0.05 for an unpaired comparison of the
averages.
Sera Isolation
Terminal bleeds were performed 5 dpi on type I and type
I:Dmaf1–infected female C57BL/6 (n= 9 per parasite strain) and
kept at 4uC for 4 h. Bleeds were then spun down at 14,0006rpm,
and sera were isolated, aliquoted into fresh tubes, and stored at
280uC until analysis.
Flow Cytometry
PECs were washed twice with FACS buffer (3% FBS in 16PBS)
and stained for 30 min with surface marker antibody CD11b-
APC-Cy7 (BD Biosciences). After staining, the cells were washed
with FACS buffer and run on an LSR II flow cytometer (Becton
Dickinson). Cells were sorted on a DIVA cell sorter (BD
Biosciences) and analyzed using FlowJo software (Tree Star). Cells
were measured as a percentage of total intact cells (determined by
forward and side scatter measurements). Infected cells were
identified by virtue of the red fluorescence of the RFP protein
expressed by the engineered Toxoplasma.
Supporting Information
Figure S1 HMA2 phenotype is consistent in type II strains.
HFFs were labeled with MitoTracker and infected with a type II
(Pru) strain. Cells were fixed 4 hpi. Scale bar, 5 mm.
(JPG)
Figure S2 HMA is strain-specific in vivo. Mice were infected
intraperitoneally with 100 type I tachyzoites or 10,000 type II
tachyzoites. At 5 dpi, PECs were isolated and processed for
electron microscopy analysis. Transmission electron micrographs
of PECs harboring (A) type I and (B) type II vacuoles are depicted.
Scale bar, 0.5 mm. (C) Percentage of the PVM associated with
mitochondria at type I and II vacuoles as determined by ImageJ
analysis of electron micrographs (n= 20 for each). Values shown
are mean 6 SEM. ****p,0.0001 using an unpaired t test.
(JPG)
Figure S3 Coinfection with Toxoplasma strains that differ in their
ability to recruit mitochondria does not alter either strain’s HMA
phenotype. HFFs were labeled with MitoTracker and co-infected
with a type II GFP+ strain (green arrowheads) and type I (A) or
type III (B) strains. Cells were fixed 4 hpi. Scale bar, 5 mm.
(JPG)
Figure S4 Phenotyping of II6III F1 progeny. Genotypes of
II6III F1 progeny are available at http://toxomap.wustl.edu.
Each column represents a different F1 as indicated in the top row.
Genotypes of progeny at chromosome II markers (one marker per
row and as indicated in the left column) are given as type II (red)
or type III (yellow). The HMA phenotype of each F1 is indicated
by a (+) or (2) below each column. The 6 for CL11 indicates an
ambiguous phenotype. The region in chromosome II implicated
by this analysis starts at the left end of chromosome II and ends at
marker KT-L379A (denoted by a black box).
(JPG)
Figure S5 Amino acid alignment based on MAF1 gene
sequences amplified via long-extension PCR from RH and
Me49. The overall amino acid sequence identity between
RH_MAF1 and ME49_MAF1 is 94.5%. The predicted signal
peptide, TM domain, and proline-rich region are indicated by
boxes, and asterisks indicate sites that were found to be
phosphorylated [30].
(JPG)
Figure S6 Generation of MAF1 knockout mutants. (A) Plasmid
MAF1LKO, used to transform type I parasites. HXGPRT is the
selectable marker driven by the Toxoplasma dihydrofolate reductase
(DHFR) promoter; the arrows represent the MAF1 open reading
frames (ORFs), and the parallel lines indicate that the number of
MAF1 copies is unknown. The thick black line represents genomic
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DNA (gDNA) and the thin black line symbolizes pMAF1LKO.
59HR and 39HR represent the 59- and 39-homology regions,
respectively, used to drive the homologous recombination. Figure
not drawn to scale. (B) gDNA from type I and type I:Dmaf1
parasites was PCR amplified for MAF1 ORF and ROP2 ORF and
analyzed by agarose gel electrophoresis. (C) Lysates from 16106
type I and type I:Dmaf1 parasites were loaded in separate lanes.
Following polyacrylamide gel electrophoresis and transfer to
nitrocellulose, the membrane was probed with polyclonal sera
against MAF1 (upper) or SAG1 (lower). (D) Type I and type
I:Dmaf1 parasites were added to HFFs, and cultures were fixed in
methanol 6 hpi. Following permeabilization, coverslips were
labeled with anti-MAF1I mouse sera followed by incubation with
secondary anti-mouse Alexa488 antibodies. Scale bar, 5 mm.
(JPG)
Figure S7 MAF1 alters immune signaling during type II
infection. MEFs were infected with type II or type II:MAF1
Toxoplasma strains, or mock-infected. At 8 hpi, RNA was isolated
from the cultures, and transcript abundance was determined using
the Affymetrix Mouse 430 2.0 chip. Top 5 hits (ranked by
normalized enrichment score) shown from GSEA_canonical
pathway (c2.cp) analysis.
(JPG)
Figure S8 Role of MAVS in HMA signaling. (A) WT and
MAVS2/2 MEFs were infected with type I or type I:Dmaf1
Toxoplasma strains at an MOI of 5. At 8 hpi, RNA was isolated
from the cultures, and transcript abundance was determined using
the Affymetrix Mouse 430 2.0 chip. Genes whose expression was
significantly different between type I infection and type I:Dmaf1
infection in WT MEFs are depicted. Colors indicate the deviation
of each gene’s signal above (yellow) and below (blue) its mean
expression value across all eight samples. (B) Percentage of the
PVM associated with mitochondria in WT and MAVS2/2 MEFs
infected with type I parasites (%HMA) as determined by ImageJ
analysis of electron micrographs (n= 20 for each). Values shown
are mean 6 SEM. ****p,0.0001 using an unpaired t test.
(JPG)
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